Automating Molina Healthcare Biologics Prior Auth for Enhanced Efficiency

Navigating Molina Healthcare's Diverse Biologics PA Landscape

Molina Healthcare, a significant payer in Medicaid managed care and ACA Marketplace plans, presents a unique set of challenges for biologics prior authorization. Their operations are heavily influenced by state-specific regulations, leading to variations in submission channels and utilization management criteria. Biologics, including TNF inhibitors, IL-17/23, IL-6, and JAK inhibitors, are high-volume, high-cost therapies demanding precise, indication-specific PA.

Key Operational Considerations for Molina Biologics PA

• **State-Specific Medical Benefit PA:** Submissions for medical-benefit biologics often route through state-specific provider portals, such as those for Molina California, Molina Texas, or Molina Florida, requiring state-aware routing.
• **Pharmacy Benefit PA:** Pharmacy-administered biologics typically leverage ePA partners like CoverMyMeds and Surescripts, dependent on Molina's state-specific PBM relationships.
• **Complex Policy Libraries:** Utilization management criteria are published via state-specific provider sites accessed through molinahealthcare.com/providers, necessitating precise policy identification.
• **Multi-Benefit Plan Rules:** D-SNP plans combine Medicare Advantage organization-determination rules with state Medicaid coverage, while Marketplace plans follow QHP-on-FFM and state insurance regulations.
• **Compliance with CMS-0057-F:** Molina's Medicaid managed-care, D-SNP MA, CHIP, and QHP-on-FFM lines are all impacted by CMS-0057-F, mandating specific decision timeframes.

Klivira's Intelligent Automation for Molina Biologics Prior Auth

Klivira's platform is engineered to address the specific demands of Molina Healthcare biologics prior auth. Our state-aware routing logic, similar to approaches for other multi-state payers, ensures that submissions align with the correct state Medicaid agency rules and Molina's internal UM operations. This targeted automation minimizes manual effort and reduces the potential for denials due to procedural errors.

Automated Workflow Features for Biologics PA

• **Indication-Specific Criteria Application:** Klivira identifies the specialty and disease state from EMR diagnoses, applying precise PA criteria for rheumatology, gastroenterology, dermatology, and other relevant fields.
• **Step Therapy Automation:** The system pulls prior-line therapy history (e.g., csDMARDs for rheumatology, 5-ASA for IBD) to fulfill step therapy requirements automatically.
• **Biosimilar Substitution Routing:** Klivira applies per-payer biosimilar mandates, ensuring compliance with Molina's preferred biosimilar policies.
• **Automated Screening Documentation:** Required screenings such as TB (PPD or IGRA), hepatitis B/C, and immunization status are extracted from FHIR-enabled EMR data.
• **Periodic Re-authorization Management:** The platform manages typical 6/12-month re-authorization cycles, prompting for continuous disease-activity and response documentation.
• **Medical vs. Pharmacy Benefit Routing:** Klivira accurately routes submissions based on whether the biologic falls under medical or pharmacy benefits, depending on the administration mode.

Streamlining Submissions and Policy Adherence with Molina

Klivira integrates directly with Molina's diverse submission channels. For medical benefit biologics, our system navigates the necessary state-specific provider portals. For pharmacy benefit biologics, Klivira connects with ePA partners like CoverMyMeds and Surescripts. By automating the extraction of clinical data from your EMR and mapping it to Molina's specific forms and policy requirements, we ensure comprehensive and accurate submissions, reducing turnaround times and improving first-pass approval rates.

Enhancing Revenue Cycle Performance and Patient Access

By automating Molina Healthcare biologics prior auth, Klivira empowers your organization to reduce administrative overhead associated with high-volume specialty drug PAs. This operational efficiency translates into faster approval times, fewer denials, and improved patient access to critical therapies. Our platform ensures that your team can focus on patient care rather than navigating complex payer workflows, ultimately enhancing financial performance and patient satisfaction.